Event-Driven Stocks

Viridian Therapeutics, Inc.\DE

VRDNNasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 4 good● 3 warningdetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$70.8M$302,000$314,000$1.8M$3.0M$1.1M
Operating income−$363.4M−$299.0M−$254.4M−$134.3M−$79.7M−$110.4M
Net income−$342.6M−$269.9M−$237.7M−$129.9M−$79.4M−$110.7M
Total assets$899.4M$742.4M$490.4M$435.1M$203.7M$131.3M
Total liabilities$177.3M$70.8M$48.4M$40.0M$16.0M$11.2M
Equity$722.2M$671.6M$442.0M$395.1M$187.7M$120.0M
EPS (diluted)——$-5.31$-4.05$-6.66$-31.13
Shares out.81.5M62.8M42.9M25.9M7.2M53.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−512.9%
Net margin
−483.6%
Return on equity
−47.4%
Return on assets
−38.1%
Return on capital (ROCE)
−43.9%
Liabilities / assets
19.7%
Debt / equity
0.25×
Book value / share
$8.86
Revenue growth (YoY)
23359.9%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
2.72safe
Accruals / assets
−7.4%clean
Piotroski F-Score
3/9weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
67
/ 100
Profitability 0Growth 100Catalyst 67Earnings quality 67Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

● 3 warning● 4 good
  • Operating losses (negative operating margin)
  • Reported a net loss
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 202614.3M3.1+23.9%
Apr 30, 202611.5M6.9+8.0%
Apr 15, 202610.7M2.6-1.7%
Mar 31, 202610.8M4.0+31.7%
Mar 13, 20268.2M7.3+5.3%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.